ArticleAmerican health & drug benefits2020

Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.

Zizi Elsisi et al.PubMed ↗Full text ↗

No numbers read from the abstract.